CAS 863029-89-4
:2-{[(4-chlor-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-5-methoxy-1H-benzimidazol
4-Chloro Omeprazole (2-[(RS)-[4-Chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormel:C16H16ClN3O2SFarbe und Form:Off-White SolidMolekulargewicht:349.065184-Desmethoxy-4-chloro Omeprazole
CAS:Formel:C16H16ClN3O2SReinheit:%Farbe und Form:SolidMolekulargewicht:349.8351Omeprazole EP Impurity H
CAS:Formel:C16H16ClN3O2SFarbe und Form:Off-White SolidMolekulargewicht:349.832-(((4-Chloro-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d]imidazole
CAS:2-(((4-Chloro-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d]imidazoleReinheit:95%Molekulargewicht:349.84g/molOmeprazole EP Impurity H
CAS:Kontrolliertes ProduktFormel:C16H16ClN3O2SFarbe und Form:NeatMolekulargewicht:349.844-Desmethoxy-4-chloro Omeprazole
CAS:Kontrolliertes ProduktImpurity Omeprazole EP Impurity H
Applications 4-Desmethoxy-4-chloro Omeprazole (Omeprazole EP Impurity H) is an Impurity D from the synthesis of Omeprazole.
References Kohl, B., et al.: J. Med. Chem., 35, 1049 (1992),Formel:C16H16ClN3O2SFarbe und Form:NeatMolekulargewicht:349.845-Methoxy-2-[[(4-Chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole
CAS:5-Methoxy-2-[(4-chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H benzimidazole is a synthetic drug product. It has been used as a positive control in metabolism studies and as an impurity standard. 5-Methoxy 2-[(4-chloro 3,5 dimethyl 2 pyridinyl)methyl]sulfinyl]-5 methoxy 1H benzimidazole is also a metabolite of the active pharmaceutical ingredient (API) which is used to develop drugs. This chemical is synthesized by custom synthesis and can be obtained at high purity levels. The metabolite of this compound is 5 methoxy 2-[(4 chloro 3,5 dimethyl 2 pyridinyl)methyl]sulfonyl]-5 methoxy 1H benzimidazole.
Formel:C16H16ClN3O2SReinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:349.84 g/mol








